Antiplatelet Therapy in HIV

Completed · Phase 2

Conditions studied: HIV, Cardiovascular Diseases, Inflammation

In brief

The proposed study will add to the growing understanding of platelet activity and platelet inhibition in subjects with HIV. It will examine the relationship between platelet activity and its inhibition by antiplatelet therapy (aspirin monotherapy and clopidogrel monotherapy) in this high-risk cohort. Furthermore, it will provide important data on the mechanism of platelet activity and its inhibition using biomarkers of platelet activity, inflammation, immune activity and endothelial function and genetic expression profiling.

Key facts

Study ID
NCT02559414
Run by
NYU Langone Health
People needed
55
Starts
2015-02-01
Expected to finish
2017-02-01
Last updated by the study team
2018-10-15

Who can join

Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.